Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Cash & Equivalents	2.85	2.62	2.56	2.87	2.79	4.43	5.25	6.15	13.03	3.74	19.14	14.74	26.12	16.46	14.46	24.16	39.45	93.93	34.48	18.37
Short-Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	5	23.65	40.01	47.74	47.79	-	-	-
Cash & Short-Term Investments	2.85	2.62	2.56	2.87	2.79	4.43	5.25	6.15	13.03	3.74	19.14	14.74	31.12	40.11	54.47	71.91	87.24	93.93	34.48	18.37
Cash Growth (YoY)	2.26%	-40.96%	-51.26%	-53.25%	-78.62%	18.33%	-72.60%	-58.30%	-58.14%	-90.67%	-64.86%	-79.51%	-64.33%	-57.29%	57.98%	291.43%	724.06%	712.50%	339.17%	8.53%
Accounts Receivable	4.55	4.81	3.39	3.52	4.46	3.12	3.38	3.71	2.09	1.67	1.53	1.31	1.17	0.32	0.87	-	-	-	-	-
Other Receivables	-	-	-	-	-	-	-	-	-	4.68	-	-	-	-	-	-	-	-	-	-
Receivables	4.55	4.81	3.39	3.52	4.46	3.12	3.38	3.71	2.09	6.34	1.53	1.31	1.17	0.32	0.87	-	-	-	-	-
Inventory	5.79	3.75	2.74	2.41	2.54	2.21	1.33	1.8	2.34	2.69	0.97	3.46	3.46	1.59	-	-	-	-	-	-
Prepaid Expenses	0.13	0.18	0.44	0.7	0.97	0.55	0.63	1.03	0.2	0.61	0.78	1.19	0.26	0.32	0.68	1.41	1.53	0.67	0.84	1.32
Other Current Assets	1.12	0.63	0.4	0.56	0.9	0.59	0.78	2.8	0.82	0.97	1.51	1.07	0.94	1.34	0.77	-	-	-	-	-
Total Current Assets	14.44	11.99	9.53	10.06	11.65	10.91	11.36	15.49	18.47	14.35	23.93	21.76	36.95	43.67	56.79	73.32	88.76	94.6	35.32	19.69
Property, Plant & Equipment	0.28	0.39	0.49	0.59	0.68	0.78	0.87	0.96	12.35	12.94	13.4	12.95	13.44	13.91	14.38	14.3	14.3	14.29	14.2	14.15
Other Long-Term Assets	0.24	0.24	0.24	0.24	0.24	2.01	2.01	2.01	2.01	2.01	2.01	1.97	1.9	1.9	1.9	1.79	-	-	0.02	-
Total Assets	14.96	12.61	10.26	10.89	12.57	13.7	14.24	18.46	32.83	29.3	39.33	36.68	52.28	59.48	73.06	89.41	103.06	108.89	49.54	33.83

Liabilities

Fiscal Quarter	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Accounts Payable	16.54	12.62	9.57	6.88	6.16	10.36	7.73	4.91	12.04	9.54	8.71	5.63	6.41	5.94	3.87	5.02	5.12	2.03	1.82	0.6
Accrued Expenses	9.4	8.44	9.13	8.34	6.75	6.31	3.91	5.15	3.88	3.83	3.56	3.9	5.15	2.74	3.35	2.15	1.29	0.65	1.8	1.11
Short-Term Debt	-	-	0.19	0.38	0.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	1.52	1.59	1.56	1.51	1.43	1.32	12.63	12.25	16.83	-	-	-	-	-	-	-	-	-
Current Portion of Leases	0.29	0.38	0.37	0.35	0.34	0.33	0.32	0.28	0.24	0.23	0.18	0.04	0.07	0.11	0.14	0.03	0.08	0.13	0.17	0.18
Total Current Liabilities	26.23	21.44	20.78	17.54	15.31	18.51	13.39	11.65	28.78	25.85	29.28	9.57	11.64	8.79	7.35	7.2	6.49	2.81	3.8	1.9
Long-Term Debt	-	-	-	-	-	-	-	-	-	-	-	16.43	16.04	15.64	16.38	16.08	15.78	15.47	-	-
Long-Term Leases	-	-	0.1	0.2	0.29	0.38	0.47	0.55	0.63	0.71	0.78	-	-	-	-	-	-	-	-	0.03
Other Long-Term Liabilities	10.65	1.49	5.7	5.57	9.1	4.25	5.93	-	-	-	5.36	-	-	-	-	-	-	-	-	-
Total Liabilities	36.88	22.93	26.57	23.3	24.69	23.13	19.79	12.2	29.41	26.56	35.42	26	27.67	24.42	23.73	23.28	22.27	18.28	3.8	1.93

Shareholders' Equity

Fiscal Quarter	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Common Stock	0.01	0.01	0	-	-	-	-	0	0	-	-	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	411.84	411.56	406.85	406.29	405.78	404.66	403.16	437.03	414.52	400.74	387.21	374.43	371.59	364.4	361.54	360.71	359.86	358.85	306.11	286.25
Retained Earnings	-433.76	-421.88	-423.17	-418.7	-417.9	-414.09	-408.7	-430.77	-411.11	-398.89	-383.29	-363.76	-346.99	-329.35	-312.22	-294.6	-279.08	-268.25	-260.37	-254.35
Comprehensive Income & Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0.01	0.01	-	-	-
Total Common Equity	-21.91	-10.32	-16.32	-12.41	-12.12	-9.43	-5.55	6.26	3.42	1.86	3.92	10.68	24.61	35.05	49.33	66.13	80.8	90.61	45.75	31.9
Shareholders' Equity	-21.91	-10.32	-16.32	-12.41	-12.12	-9.43	-5.55	6.26	3.42	2.74	3.92	10.68	24.61	35.05	49.33	66.13	80.8	90.61	45.75	31.9
Total Liabilities & Equity	14.96	12.61	10.26	10.89	12.57	13.7	14.24	18.46	32.83	29.3	39.33	36.68	52.28	59.48	73.06	89.41	103.06	108.89	49.54	33.83

Additional Metrics

Fiscal Quarter	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Total Debt	0.29	0.38	2.17	2.52	2.69	2.22	2.21	2.15	13.5	13.19	17.79	16.47	16.11	15.74	16.52	16.11	15.86	15.6	0.17	0.21
Net Cash (Debt)	2.56	2.24	0.39	0.36	0.09	2.21	3.04	4	-0.47	-9.45	1.35	-1.74	15.01	24.37	37.95	55.79	71.38	78.33	34.31	18.16
Net Cash Growth (YoY)	2712.09%	1.08%	-87.31%	-91.10%	-	-	124.65%	-	-	-	-96.44%	-	-78.97%	-68.89%	10.63%	207.26%	590.51%	594.68%	336.98%	64.76%
Net Cash Per Share	0.37	0.48	0.13	0.12	0.05	2.43	3.68	5.41	-5.23	-151.64	22.91	-37.03	338.47	556.20	867.99	1277.46	1636.70	2043.65	1096.77	677.41
Filing Date Shares Outstanding	6.9	6.86	6.86	2.51	1.93	0.99	0.93	0.81	0.78	0.09	0.07	0.06	0.05	0.04	0.04	0.04	0.04	0.04	0.03	0.03
Total Common Shares Outstanding	6.9	6.86	2.96	2.28	1.64	0.93	0.86	0.78	0.25	0.07	0.06	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.03	0.03
Working Capital	-11.79	-9.45	-11.25	-7.47	-3.66	-7.6	-2.03	3.83	-10.31	-11.5	-5.35	12.19	25.31	34.89	49.43	66.12	82.27	91.79	31.52	17.79
Book Value Per Share	-3.17	-1.51	-5.51	-5.45	-7.39	-10.12	-6.45	8.02	13.83	27.57	64.50	225.48	529.64	794.30	1126.67	1512.68	1851.04	2077.81	1310.56	1075.95
Tangible Book Value	-21.91	-10.32	-16.32	-12.41	-12.12	-9.43	-5.55	6.26	3.42	1.86	3.92	10.68	24.61	35.05	49.33	66.13	80.8	90.61	45.75	31.9
Tangible Book Value Per Share	-3.17	-1.51	-5.51	-5.45	-7.39	-10.12	-6.45	8.02	13.83	27.57	64.50	225.48	529.64	794.30	1126.67	1512.68	1851.04	2077.81	1310.56	1075.95
Machinery	-	-	0.25	-	-	-	0.25	-	-	-	14.6	-	-	-	14.33	-	-	-	14.43	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error